INSM FY 2018 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M

Gross Profit

$7M75.4% margin

Operating Income

-$307M-3124.9% margin

Net Income

-$324M-3297.2% margin

EPS (Diluted)

$-4.22

Cash Flow

Operating Cash Flow

-$258M

Free Cash Flow

-$273M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$605M

Total Liabilities

$396M

Stockholders' Equity

$208M

Cash & Equivalents

$495M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$0	—
Gross Profit	$7M	-$3M	+355.5%
Operating Income	-$307M	-$189M	-62.7%
Net Income	-$324M	-$193M	-68.3%